...
首页> 外文期刊>Cephalalgia >Sustained response to botulinum toxin in SUNCT syndrome
【24h】

Sustained response to botulinum toxin in SUNCT syndrome

机译:SUNCT综合征对肉毒毒素的持续反应

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Introduction: Short-lasting, unilateral, neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) is a rare condition grouped in the category of trigeminal autonomic cephalalgia. The syndrome is characterized by very frequent, unilateral attacks of pain in the ocular and periocular region accompanied by ipsilateral conjunctival injection and lacrimation. The aetiology is unknown, although there have been reports of cases secondary to structural lesions, and treatment is usually ineffective.Patients and Methods: We present the case of a patient diagnosed with SUNCT refractory to pharmacological treatment; duration of the SUNCT was 20 years. OnabotulinumtoxinA was infiltrated at four points around the orbit.Results: The pain showed a dramatic response to onabotulinumtoxinA infiltration. Efficacy has been maintained for 18 months with 3-monthly infiltrations, with no adverse effects.Conclusions: OnabotulinumtoxinA should be added to the limited therapeutic arsenal available for the treatment of refractory cases of SUNCT.
机译:简介:伴有结膜注射和撕裂(SUNCT)的持续性,单侧神经样头痛发作是三叉神经自主性头痛的一种罕见病。该综合征的特征是眼球和眼周区域出现非常频繁的单侧疼痛发作,并伴有同侧结膜注射和流泪。病因不明,尽管已有报道继发于结构性病变的病例,并且治疗通常无效。患者和方法:我们介绍了一名被确诊为SUNCT难治性药物治疗的患者。 SUNCT的持续时间为20年。结果:肉毒杆菌毒素A在眼眶周围四处浸润。结果:疼痛显示出对肉毒杆菌毒素A浸润的剧烈反应。疗效保持18个月,每月浸润3个月,无不良反应。结论:应在有限的治疗性阿森纳中添加OnabotulinumtoxinA,以治疗SUNCT的难治性病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号